Global telehealth and telemedicine market is anticipated to witness significant growth in the coming years owing to rising awareness about the various advantages associated with the technologies and increasing prevalence of chronic diseases.
Home>Industry Reports>Global Telehealth and Telemedicine Market Assessment, Opportunities and Forecast, 2017-2031F
Global telehealth and telemedicine market is projected to witness a CAGR of 15.47% during the forecast period 2024-2031, growing from USD 109.61 billion in 2023 to USD 346.44 billion in 2031F. The market's growth is supported by the rise in the number of chronic diseases, expansion of the healthcare sector, digitization of healthcare, growing awareness about the various advantages of telehealth and telemedicine technologies and increasing government efforts.
The rise in government efforts to bolster product utilization is one of the crucial global telehealth and telemedicine market trends. In November 2023, the national railway company of France announced that it would deploy telemedicine services by 2028 across 300 train stations. The selected stations are in concerted development and priority intervention zones that do not have sufficient healthcare offerings. Such investments are expected to propel the market demand and positively influence the expansion of the market in the coming years.
The adoption of telehealth and telemedicine is also anticipated to increase owing to the ability of the technologies to reduce greenhouse gas emissions associated with cancer care. According to a study published in JAMA Oncology in June 2024, a substantial reduction of emissions was witnessed with decentralized cancer care. In the cohort study that included 123,890 patients seen over 1.6 million visit days, the telemedicine care model reduced per-visit day emissions by 81.3% compared to the in-person care model. In the national counterfactual model, which compared decentralized care (local site care as well as telemedicine when possible) and usual care, a reduction of 33.1% in emissions was witnessed. The cohort study concluded that telehealth has the potential to reduce the greenhouse gas emissions generated by cancer care substantially.
The rise in collaborations between various healthcare companies to enhance access to different healthcare facilities in order to improve patient outcomes is expected to support the growth of the market. For instance, in June 2024, Infosys Technologies Private Limited announced partnerships with NIHON CHOUZAI Co., Ltd. and developed a mobile application for NiCOMS, allowing patients to receive medication guidance from pharmacists remotely. With this collaboration, the companies aim to enhance medical services and boost access to high-quality pharmaceutical interventions in Japan. Such developments are anticipated to enhance patient comfort by allowing patients to connect with healthcare professionals and conveniently receive medication and disease management instructions.
The increasing awareness about the different advantages associated with the utilization of telehealth and telemedicine products and services is expected to provide lucrative growth opportunities to the market. The utilization of telehealth and telemedicine aids in providing individuals with mobility limitations access to healthcare. Meanwhile, in the case of chronic condition management, telemedicine allows the patient to connect with the doctor or other healthcare professional and aids in forming long term relationships and also get counseling and mental health assessment in case of requirement in a seamless manner.
The time and cost efficiency offered by these technologies are also bolstering their usage in different regions across the globe. According to a study published in JAMA Network in January 2023, telehealth was associated with savings in travel costs and patient time and can aid in the economic burden associated with treatments. The study included 11,688 patients with 25,496 telehealth visits and showcased that telehealth accounted for an estimated savings of USD 467,247 in lost income due to visit time and USD 11,70,160 in lost income due to driving time.
The market growth in the region is aided by the rising prevalence of different chronic conditions, the expanding healthcare sector, and increasing investments in healthcare IT. According to the American Cancer Society, in 2024, 611,720 cancer-related deaths and 2,001,140 new cases are estimated to occur in the United States. This increase bolsters the utilization of telehealth and telemedicine technologies as they aid the caretakers of patients with advanced cancer in providing quality care to their patients by reducing the burden associated with regular hospital visits. They also aid patients in reducing various indirect costs associated with regular doctor visits, including travel expenses and loss of income due to taking time off work to accommodate medical visits and travel. Due to the advantages of telehealth and telemedicine and the increasing acceptance of remote consultation, the market is witnessing significant growth in North America in the coming years.
The software segment is expected to witness significant growth in the coming years owing to the various advantages associated with their usage, including safety, convenience, and cost efficiency. Software helps effectively manage chronic diseases, monitor different health conditions, and ensure adherence to medication is practiced. Additionally, the segment's growth is also supported by the rising investments by various companies towards upgrading their software to enhance the quality of care provided to patients, propelling the global telehealth and telemedicine market. In June 2024, telehealth company TytoCare Ltd. announced that it was releasing an update for its Home Smart Clinic software to allow patients access to urgent, primary, and specialty care and make the telehealth experience seamless. The update will also increase the number of healthcare providers patients can connect with, allow patients to record vital data before the visit, and provide a link for every appointment, which will be rolled out to the patients and providers in the coming months.
Future Market Scenario (2024-2031F)
According to the global telehealth and telemedicine market analysis, the requirement for telehealth and telemedicine is expected to increase significantly over the forecast period owing to their ability to streamline the workflow of clinics and hospitals, which is becoming essential as the population expands and the prevalence of chronic diseases increases. These technologies often emphasize high-value tasks and reduce the burden associated with patient check-ins while providing coverage to individuals in rural locations with limited treatment and consultation options.
A rise in research and development activities will also support market growth. For instance, an interventional study, which is expected to conclude in October 2024, is being conducted to evaluate how telehealth exercises aid in enhancing cardiovascular health in lymphoma survivors. Meanwhile, an interventional study is also being conducted to evaluate whether telemedicine follow-ups for patients with leg ulcers and diabetes-related foot ulcers are a viable alternative to traditional follow-ups. The study is expected to conclude in December 2024.
Report Scope
“Telehealth and Telemedicine Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global telehealth and telemedicine market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business model, competitive intelligence, etc.
Report Attribute |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2017-2022 |
Forecast Period |
2024-2031F |
Projected Growth Rate |
CAGR of 15.47% between 2024-2031F |
Revenue Forecast in 2031 |
USD 346.44 billion |
Segments Covered |
Component, Mode of Delivery, Application, End-user |
Regions Covered |
North America, Europe, South America, Asia-Pacific, Middle East and Africa |
Key Companies Profiled |
Koninklijke Philips N.V., Veradigm LLC, Medtronic, plc, Siemens Healthineers AG, Cisco Systems, Inc., Oracle Healthcare Private Limited, GE HealthCare Technologies, Inc., Teladoc Health, Inc., MDLIVE Inc., American Well Corporation |
Customization Scope |
15% free report customization with purchase |
Pricing and Purchase Options |
Avail the customized purchase options to fulfill your precise research needs |
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, the global telehealth and telemedicine market has been segmented into the following categories:
Key Players Landscape and Outlook
The growth of the market is boosted by the increasing collaborations between the key market players and insurance benefits and assistance service companies. For instance, in June 2024, International Medical Group, Inc. and Teladoc Health, Inc. announced the expansion of their partnership. This partnership will expand the International Medical Group’s offerings of telehealth services with the utilization of Teladoc’s All360Health, an easy-to-use platform available for prescription and telehealth services. With this platform travelers can connect with healthcare experts across the globe via online video and phone consultations. Such partnerships are expected to aid the market players in expanding their customer base and boost the global telehealth and telemedicine market size.
Key Players Operating in the Global Telehealth and Telemedicine Market are:
Markets and Data report answers the following questions:
If you can't find what you're searching for or have any custom requirements for the global telehealth and telemedicine market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope and Definitions
3. Executive Summary
4. Global Telehealth and Telemedicine Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.By Value
4.2.1.Software
4.2.1.1. Integrated Software
4.2.1.2. Standalone Software
4.2.2.Hardware
4.2.2.1. Monitors
4.2.2.2. Medical Peripheral Devices
4.2.2.2.1. Blood Pressure Meters
4.2.2.2.2. Blood Glucose Meters
4.2.2.2.3. Peak Flow Meters
4.2.2.2.4. ECG Monitors
4.2.2.2.5. Pulse Oximeters
4.2.2.2.6. Weighing Scales
4.2.2.2.7. Others
4.2.3.Services
4.3. By Mode of Delivery
4.3.1.On-premise
4.3.2.Cloud-based
4.4. By Application
4.4.1.Teleconsultation
4.4.2.Remote Patient Monitoring
4.4.3.Telepathology
4.4.4.Telepsychiatry
4.4.5.Teledermatology
4.4.6.Others
4.5. By End-user
4.5.1.Payers
4.5.1.1. Private
4.5.1.2. Public
4.5.2.Providers
4.5.2.1. Hospitals and Clinics
4.5.2.2. Assisted Living Centers and Long-Term Care Centers
4.5.3.Patients
4.6. By Region
4.6.1.North America
4.6.2.South America
4.6.3.Europe
4.6.4.Asia-Pacific
4.6.5.Middle East and Africa
4.7. By Company Market Share (%), 2023
5. Global Telehealth and Telemedicine Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. By Value
5.1.2.By Component
5.1.2.1. Software
5.1.2.1.1. Integrated Software
5.1.2.1.2. Standalone Software
5.1.2.2. Hardware
5.1.2.2.1. Monitors
5.1.2.2.2. Medical Peripheral Devices
5.1.2.2.2.1. Blood Pressure Meters
5.1.2.2.2.2. Blood Glucose Meters
5.1.2.2.2.3. Peak Flow Meters
5.1.2.2.2.4. ECG Monitors
5.1.2.2.2.5. Pulse Oximeters
5.1.2.2.2.6. Weighing Scales
5.1.2.2.2.7. Others
5.1.2.3. Services
5.1.3.By Mode of Delivery
5.1.3.1. On-premise
5.1.3.2. Cloud-based
5.1.4.By Application
5.1.4.1. Teleconsultation
5.1.4.2. Remote Patient Monitoring
5.1.4.3. Telepathology
5.1.4.4. Telepsychiatry
5.1.4.5. Teledermatology
5.1.4.6. Others
5.1.5.By End-user
5.1.5.1. Payers
5.1.5.1.1. Private
5.1.5.1.2. Public
5.1.5.2. Providers
5.1.5.2.1. Hospitals and Clinics
5.1.5.2.2. Assisted Living Centers and Long-Term Care Centers
5.1.5.3. Patients
5.1.6.United States*
5.1.6.1. Market Size & Forecast
5.1.6.1.1. By Value
5.1.6.2. By Component
5.1.6.2.1. Software
5.1.6.2.1.1. Integrated Software
5.1.6.2.1.2. Standalone Software
5.1.6.2.2. Hardware
5.1.6.2.2.1. Monitors
5.1.6.2.2.2. Medical Peripheral Devices
5.1.6.2.2.2.1. Blood Pressure Meters
5.1.6.2.2.2.2. Blood Glucose Meters
5.1.6.2.2.2.3. Peak Flow Meters
5.1.6.2.2.2.4. ECG Monitors
5.1.6.2.2.2.5. Pulse Oximeters
5.1.6.2.2.2.6. Weighing Scales
5.1.6.2.2.2.7. Others
5.1.6.2.3. Services
5.1.6.3. By Mode of Delivery
5.1.6.3.1. On-premise
5.1.6.3.2. Cloud-based
5.1.6.4. By Application
5.1.6.4.1. Teleconsultation
5.1.6.4.2. Remote Patient Monitoring
5.1.6.4.3. Telepathology
5.1.6.4.4. Telepsychiatry
5.1.6.4.5. Teledermatology
5.1.6.4.6. Others
5.1.6.5. By End-user
5.1.6.5.1. Payers
5.1.6.5.1.1. Private
5.1.6.5.1.2. Public
5.1.6.5.2. Providers
5.1.6.5.2.1. Hospitals and Clinics
5.1.6.5.2.2. Assisted Living Centers and Long-Term Care Centers
5.1.6.5.2.3. Patients
5.1.7.Canada
5.1.8.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. Asia-Pacific
5.3.1.India
5.3.2.China
5.3.3.Japan
5.3.4.Australia
5.3.5.Vietnam
5.3.6.South Korea
5.3.7.Indonesia
5.3.8.Philippines
5.4. South America
5.4.1.Brazil
5.4.2.Argentina
5.5. Middle East and Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Component
6.2. By Mode of Delivery
6.3. By Application
6.4. By End-user
6.5. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Value Chain Analysis
7.3. PESTEL Analysis
7.3.1. Political Factors
7.3.2. Economic System
7.3.3. Social Implications
7.3.4. Technological Advancements
7.3.5. Environmental Impacts
7.3.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.4. Porter’s Five Forces Analysis
7.4.1. Supplier Power
7.4.2. Buyer Power
7.4.3. Substitution Threat
7.4.4. Threat from New Entrant
7.4.5. Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Case Studies
12. Key Players Outlook
12.1. Koninklijke Philips N.V.
12.1.1. Company Details
12.1.2. Key Management Personnel
12.1.3. Products and Services
12.1.4. Financials (As reported)
12.1.5. Key Market Focus and Geographical Presence
12.1.6. Recent Developments
12.2. Veradigm LLC
12.3. Medtronic, plc
12.4. Siemens Healthineers AG
12.5. Cisco Systems, Inc.
12.6. Oracle Healthcare Private Limited
12.7. GE HealthCare Technologies, Inc.
12.8. Teladoc Health, Inc.
12.9. MDLIVE Inc.
12.10. American Well Corporation
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
13. Strategic Recommendations
14. About Us & Disclaimer
List of Figures
Figure 1. Global Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 3. Global Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 4. Global Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 5. Global Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 6. Global Telehealth and Telemedicine Market Share (%), By Region, 2017-2031F
Figure 7. North America Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 8. North America Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 9. North America Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 10. North America Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 11. North America Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 12. North America Telehealth and Telemedicine Market Share (%), By Country, 2017-2031F
Figure 13. United States Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 14. United States Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 15. United States Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 16. United States Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 17. United States Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 18. Canada Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 19. Canada Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 20. Canada Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 21. Canada Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 22. Canada Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 23. Mexico Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 24. Mexico Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 25. Mexico Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 26. Mexico Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 27. Mexico Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 28. Europe Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 29. Europe Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 30. Europe Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 31. Europe Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 32. Europe Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Telehealth and Telemedicine Market Share (%), By Country, 2017-2031F
Figure 34. Germany Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 35. Germany Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 36. Germany Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 37. Germany Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 38. Germany Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 39. France Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 40. France Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 41. France Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 42. France Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 43. France Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 44. Italy Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 45. Italy Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 46. Italy Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 47. Italy Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 48. Italy Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 49. United Kingdom Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 50. United Kingdom Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 51. United Kingdom Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 52. United Kingdom Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 53. United Kingdom Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 54. Russia Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 55. Russia Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 56. Russia Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 57. Russia Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 58. Russia Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 59. Netherlands Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 60. Netherlands Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 61. Netherlands Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 62. Netherlands Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 63. Netherlands Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 64. Spain Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 65. Spain Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 66. Spain Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 67. Spain Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 68. Spain Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 69. Turkey Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 70. Turkey Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 71. Turkey Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 72. Turkey Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 73. Turkey Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 74. Poland Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 75. Poland Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 76. Poland Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 77. Poland Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 78. Poland Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 79. South America Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 80. South America Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 81. South America Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 82. South America Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 83. South America Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 84. South America Telehealth and Telemedicine Market Share (%), By Country, 2017-2031F
Figure 85. Brazil Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 86. Brazil Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 87. Brazil Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 88. Brazil Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 89. Brazil Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 90. Argentina Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 91. Argentina Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 92. Argentina Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 93. Argentina Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 94. Argentina Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 95. Asia-Pacific Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 96. Asia-Pacific Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 97. Asia-Pacific Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 98. Asia-Pacific Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 99. Asia-Pacific Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 100. Asia-Pacific Telehealth and Telemedicine Market Share (%), By Country, 2017-2031F
Figure 101. India Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 102. India Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 103. India Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 104. India Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 105. India Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 106. China Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 107. China Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 108. China Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 109. China Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 110. China Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 111. Japan Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 112. Japan Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 113. Japan Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 114. Japan Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 115. Japan Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 116. Australia Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 117. Australia Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 118. Australia Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 119. Australia Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 120. Australia Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 121. Vietnam Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 122. Vietnam Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 123. Vietnam Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 124. Vietnam Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 125. Vietnam Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 126. South Korea Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 127. South Korea Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 128. South Korea Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 129. South Korea Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 130. South Korea Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 131. Indonesia Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 132. Indonesia Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 133. Indonesia Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 134. Indonesia Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 135. Indonesia Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 136. Philippines Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 137. Philippines Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 138. Philippines Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 139. Philippines Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 140. Philippines Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 141. Middle East & Africa Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 142. Middle East & Africa Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 143. Middle East & Africa Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 144. Middle East & Africa Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 145. Middle East & Africa Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 146. Middle East & Africa Telehealth and Telemedicine Market Share (%), By Country, 2017-2031F
Figure 147. Saudi Arabia Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 148. Saudi Arabia Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 149. Saudi Arabia Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 150. Saudi Arabia Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 151. Saudi Arabia Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 152. UAE Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 153. UAE Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 154. UAE Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 155. UAE Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 156. UAE Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 157. South Africa Telehealth and Telemedicine Market, By Value, In USD Billion, 2017-2031F
Figure 158. South Africa Telehealth and Telemedicine Market Share (%), By Component, 2017-2031F
Figure 159. South Africa Telehealth and Telemedicine Market Share (%), By Mode of Delivery, 2017-2031F
Figure 160. South Africa Telehealth and Telemedicine Market Share (%), By Application, 2017-2031F
Figure 161. South Africa Telehealth and Telemedicine Market Share (%), By End-user, 2017-2031F
Figure 162. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 163. By Mode of Delivery Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Global light commercial vehicle tire market is projected to grow due to the growing e-commerce sector, flooding logistics activities, and rising number of multiple infrastructural projects.....Read More
Published on
July 2024
4,500
Global mobile and tablet case market is anticipated to grow due to its utility in protection against physical damages, addition of water and dust resistance properties and introduction of stylish and quirky designs with durable materials to cater to ....Read More
Published on
July 2024
4,500
Global pea protein market is witnessing expansion due to consumers’ shift towards plant-based proteins.....Read More
Published on
July 2024
4,500
Global soup market is witnessing expansion due to its longer shelf life and convenience in consumption.....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US